| 000 | 01876 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513185340.0 | ||
| 264 | 0 | _c19990805 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrijanovski, O I | |
| 245 | 0 | 0 |
_aKeratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. _h[electronic resource] |
| 260 |
_bBlood _cJul 1999 |
||
| 300 |
_a825-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aEpithelial Cells _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibroblast Growth Factor 10 |
| 650 | 0 | 4 | _aFibroblast Growth Factor 7 |
| 650 | 0 | 4 | _aFibroblast Growth Factors |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xdrug therapy |
| 650 | 0 | 4 |
_aGraft vs Tumor Effect _xdrug effects |
| 650 | 0 | 4 |
_aGrowth Substances _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xbiosynthesis |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 |
_aLeukemia, Experimental _xtherapy |
| 650 | 0 | 4 |
_aLipopolysaccharides _xblood |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aRadiation Chimera |
| 650 | 0 | 4 |
_aRadiation Injuries, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 |
_aTransplantation, Homologous _xadverse effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
| 700 | 1 | _aHill, G R | |
| 700 | 1 | _aCooke, K R | |
| 700 | 1 | _aTeshima, T | |
| 700 | 1 | _aCrawford, J M | |
| 700 | 1 | _aBrinson, Y S | |
| 700 | 1 | _aFerrara, J L | |
| 773 | 0 |
_tBlood _gvol. 94 _gno. 2 _gp. 825-31 |
|
| 999 |
_c10356029 _d10356029 |
||